You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Roche Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ROCHE, and what generic and branded alternatives to ROCHE drugs are available?

ROCHE has sixty-one approved drugs.



Summary for Roche
US Patents:0
Tradenames:49
Ingredients:45
NDAs:61
Patent Litigation for Roche: See patent lawsuits for Roche

Drugs and US Patents for Roche

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche ENDEP amitriptyline hydrochloride CONCENTRATE;ORAL 085749-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-002 Mar 11, 1994 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial
Roche TAMIFLU oseltamivir phosphate FOR SUSPENSION;ORAL 021246-001 Dec 14, 2000 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Roche NOLUDAR methyprylon TABLET;ORAL 009660-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Roche Palo CELLCEPT mycophenolate mofetil FOR SUSPENSION;ORAL 050759-001 Oct 1, 1998 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Roche GANTRISIN sulfisoxazole diolamine INJECTABLE;INJECTION 006917-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Roche

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche HIVID zalcitabine TABLET;ORAL 020199-002 Jun 19, 1992 4,879,277 ⤷  Try a Trial
Roche TAMIFLU oseltamivir phosphate FOR SUSPENSION;ORAL 021246-002 Mar 21, 2011 5,866,601*PED ⤷  Try a Trial
Roche DEMADEX torsemide INJECTABLE;INJECTION 020137-002 Aug 23, 1993 4,861,786 ⤷  Try a Trial
Roche Palo CELLCEPT mycophenolate mofetil hydrochloride INJECTABLE;INJECTION 050758-001 Aug 12, 1998 5,543,408 ⤷  Try a Trial
Roche KYTRIL granisetron hydrochloride TABLET;ORAL 020305-001 Mar 16, 1995 4,886,808 ⤷  Try a Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-004 Dec 23, 1997 4,305,502 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ROCHE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 1 mg/mL, 3 mL Vial ➤ Subscribe 2007-08-31
➤ Subscribe For Oral Suspension 200 mg/mL ➤ Subscribe 2011-03-25
➤ Subscribe Capsules 30 mg and 45 mg ➤ Subscribe 2011-08-02
➤ Subscribe Injection 0.1 mg/mL, 1 mL single dose vial ➤ Subscribe 2007-03-08
➤ Subscribe Injection 1 mg/mL, 4 mL multi-dose vials ➤ Subscribe 2004-07-19
➤ Subscribe Tablets 2.5 mg and 150 mg ➤ Subscribe 2007-05-16
➤ Subscribe Capsule 75 mg ➤ Subscribe 2010-11-15
➤ Subscribe Oral Suspension 6 mg/mL ➤ Subscribe 2015-06-18
➤ Subscribe Injection 1 mg/mL, 1 mL vials ➤ Subscribe 2004-06-01
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.